Specialized in complex tumors – Dr. Ozadli is trained at Ankara Oncology Hospital Medical Oncology Clinic.
Prof. Elke Jaeger is one of Germany's top oncologists, specializing in sarcoma and heading the Oncology and Hematology department at Nordwest Clinic.
Dr. Yildiz has published extensively on neuroendocrine tumors and adrenal-related conditions, with research featured in international medical journals.
Dr. Levin coordinates the national pediatric sarcoma program, treating bone and soft tissue cancers. He studied at a leading global orthopedic oncology center in Italy.
Professor Mustafa Ondzhel specializes in oncosurgery with a focus on colorectal and adrenal tumors at Medipol Mega University Hospital.
Director of oncology hospitalization at Tel Aviv Medical Center, Ichilov, Dr. Stepfansky leads clinical studies in oncology phases 1-3.
Specializes in rare tumors, including adrenal cancers, with extensive academic research and clinical practice in medical oncology.
Univ. Prof. Dr. Wolfgang Köstler is a distinguished Austrian medical oncologist specializing in targeted cancer therapies, with over two decades of experience.
Prof. Klaus Kaczirek is a leading endocrine surgeon with over 25 years of experience of experience, specializing in adrenal tumors at Wiener Privatklinik.
Dr. Fox leads the Clinic for Haematology, Oncology and Palliative Care at BKZ Solingen – a certified interdisciplinary cancer center.
Professor Keil specializes in diagnostic and interventional radiology, with extensive experience in adrenal tumor imaging and treatment at Academic Hospital Solingen.
Associate Professor Dr. Yusuf Acikgoz has advanced training in adrenal tumors from Ohio State University and leads trials for new treatments at Lokman Hekim University.
Dr. Alemdar specializes in adrenal tumors with training at Akdeniz University Hospital – a leading center for oncology care.
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.
Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.
Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).
Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).
Assoc. Prof. Nail Paksoy combines 15 years of experience of specialized oncology experience with active participation in 8 international cancer trials at Medipol Bahçelievler Hospital.
Trained in advanced laparoscopic surgery at Istanbul University – specializes in minimally invasive adrenal tumor procedures.
Dr. Volkan Kinas specializes in oncological surgery with a focus on complex tumor cases at Büyük Anadolu Hospitals.
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.